Trial intelligence / Profile preview

Albendazole-based community intervention for Taenia solium cysticercosis in Lao PDR

ACTRN12614001067662Phase 2Active, not recruiting

Sponsor
Australian Centre for Disease Preparedness
Start
Oct 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label trial of albendazole in cysticercosis and Soil-Transmitted Helminthiases (STH), sponsored by Australian Centre for Disease Preparedness. Started Oct 2013; status: active, not recruiting.

02

Drugs

albendazole
03

Conditions

cysticercosisSoil-Transmitted Helminthiases (STH)

Beyond the preview

Go deeper on ACTRN12614001067662.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12614001067662.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call